The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of fruquintinib as second or further-line therapy for patients with advanced biliary tract cancer.
 
Pengfei Zhang
No Relationships to Disclose
 
Yu Yang
No Relationships to Disclose
 
Hongfeng Gou
No Relationships to Disclose
 
Qiu Li
No Relationships to Disclose